Skip to main content

Table 3 Rates of MCID and PASS

From: Hyperlipidemia does not influence clinical outcome in arthroscopic treatment of femoroacetabular impingement syndrome

 

Study group

Control group

P-value

MCID

HOS-ADL

27 (64.3)

31 (73.8)

0.513

HOS-SSS

24 (57.1)

25 (59.5)

0.825

iHOT-12

26 (61.9)

26 (61.9)

> 0.999

mHHS

29 (69)

33 (78.6)

0.321

PASS

HOS-ADL

19 (45.2)

22 (52.4)

0.345

HOS-SSS

18 (42.9)

21 (50.0)

0.512

iHOT-12

24 (57.1)

23 (54.8)

0.826

mHHS

20 (47.6)

24 (57.1)

0.382

  1. Data are shown as n (%)
  2. HOS-ADL Hip outcome scored-activities of daily living, HOS-SSS Hip outcome score-sport-specific subscale, IHOT-12 International hip outcome tool 12-component form, mHHS modified Harris hip score
Back to article page

Journal of Orthopaedic Surgery and Research

ISSN: 1749-799X